Plain-English translation of NCT07337525 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a first-in-human study testing a new experimental medication called in patients with advanced solid tumors. Researchers want to understand how safe this treatment is, how your body processes it, and whether it may help shrink tumors. The study starts with one patient and gradually increases the dose in small groups to find the safest and most effective amount.
This medication is brand new and has never been tested in people before. Researchers need to understand how the treatment affects the human body, what side effects patients might experience, and whether it has promise as a cancer therapy before larger studies can begin.
You likely qualify if…
You likely don't qualify if…
You would receive the medication through an intravenous infusion (IV) once every 3 weeks. The study starts by carefully giving the medication to see how your body responds, and the dose may be increased over time as researchers confirm safety. Throughout the trial, you would have regular visits for blood tests, imaging scans, and check-ins to monitor how you are doing and watch for any side effects.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States